Pregled bibliografske jedinice broj: 1238598
Impact of the pre-examination phase on multicenter metabolomic studies
Impact of the pre-examination phase on multicenter metabolomic studies // New Biotechnology, 68 (2022), 37-47 doi:10.1016/j.nbt.2022.01.006 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1238598 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Impact of the pre-examination phase on multicenter
metabolomic studies
Autori
Ghini, Veronica ; Abuja, Peter M. ; Polašek, Ozren ; Kozera, Lukasz ; Laiho, Paivi ; Anton, Gabriele ; Zins, Marie ; Klovins, Janis ; Metspalu, Andres ; Wichmann, H-Erich ; Gieger, Christian ; Luchinat, Claudio ; Zatloukal, Kurt ; Turano, Paola
Izvornik
New Biotechnology (1871-6784) 68
(2022);
37-47
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Metabolomics ; Pre-analytical procedures ; NMR ; Biobanks
Sažetak
The development of metabolomics in clinical applications has been limited by the lack of validation in large multicenter studies. Large population cohorts and their biobanks are a valuable resource for acquiring insights into molecular disease mechanisms. Nevertheless, most of their collections are not tailored for metabolomics and have been created without specific attention to the pre-analytical requirements for high-quality metabolome assessment. Thus, comparing samples obtained by different pre-analytical procedures remains a major challenge. Here, H-1 NMR-based analyses are used to demonstrate how human serum and plasma samples collected with different operating procedures within several large European cohort studies from the Biobanking and Biomolecular Resources Infrastructure - Large Prospective Cohorts (BBMRI-LPC) consortium can be easily revealed by supervised multivariate statistical analyses at the initial stages of the process, to avoid biases in the downstream analysis. The inter-biobank differences are discussed in terms of deviations from the validated CEN/TS 16945:2016 / ISO 23118:2021 norms. It clearly emerges that biobanks must adhere to the evidence-based guidelines in order to support wider-scale application of metabolomics in biomedicine, and that NMR spectroscopy is informative in comparing the quality of different sample sources in multi cohort/center studies.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE